NBT Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.43M Sell
56,481
-1,055
-2% -$61.5K 0.22% 103
2025
Q4
$3.12M Sell
57,536
-963
-2% -$46.3K 0.2% 115
2025
Q3
$2.65M Sell
58,499
-2,431
-4% -$114K 0.17% 126
2025
Q2
$2.82M Sell
60,930
-16,600
-21% -$815K 0.19% 115
2025
Q1
$4.73M Sell
77,530
-3,194
-4% -$186K 0.34% 78
2024
Q4
$4.57M Sell
80,724
-415
-0.5% -$23.2K 0.32% 82
2024
Q3
$4.2M Sell
81,139
-7,021
-8% -$329K 0.28% 87
2024
Q2
$3.66M Sell
88,160
-6,011
-6% -$269K 0.26% 93
2024
Q1
$5.11M Sell
94,171
-4,437
-4% -$226K 0.37% 63
2023
Q4
$5.06M Sell
98,608
-495
-0.5% -$26K 0.4% 63
2023
Q3
$5.75M Buy
99,103
+14,940
+18% +$915K 0.55% 47
2023
Q2
$5.38M Sell
84,163
-2,952
-3% -$198K 0.77% 33
2023
Q1
$6.04M Sell
87,115
-1,072
-1% -$75.6K 0.88% 30
2022
Q4
$6.35M Sell
88,187
-1,332
-1% -$100K 0.92% 28
2022
Q3
$6.36M Sell
89,519
-481
-0.5% -$34.9K 1.04% 25
2022
Q2
$6.93M Sell
90,000
-117
-0.1% -$8.91K 1.06% 25
2022
Q1
$6.58M Sell
90,117
-3,304
-4% -$222K 0.88% 30
2021
Q4
$5.82M Sell
93,421
-5,000
-5% -$293K 0.75% 38
2021
Q3
$5.82M Sell
98,421
-810
-0.8% -$53.3K 0.81% 36
2021
Q2
$6.63M Sell
99,231
-832
-0.8% -$54.3K 0.91% 31
2021
Q1
$6.32M Sell
100,063
-4,295
-4% -$267K 0.91% 31
2020
Q4
$6.47M Sell
104,358
-9,848
-9% -$606K 0.98% 25
2020
Q3
$6.88M Buy
114,206
+10,197
+10% +$614K 1.15% 20
2020
Q2
$6.12M Sell
104,009
-4,030
-4% -$241K 1.09% 22
2020
Q1
$6.02M Sell
108,039
-2,560
-2% -$156K 1.23% 19
2019
Q4
$7.1M Buy
110,599
+6,802
+7% +$390K 1.12% 22
2019
Q3
$5.26M Sell
103,797
-1,577
-1% -$74.1K 0.92% 31
2019
Q2
$4.78M Buy
105,374
+1,905
+2% +$88.7K 0.86% 32
2019
Q1
$4.94M Buy
103,469
+1,395
+1% +$69.5K 0.9% 32
2018
Q4
$5.3M Buy
102,074
+2,613
+3% +$140K 0.86% 29
2018
Q3
$6.17M Sell
99,461
-2,150
-2% -$128K 1% 29
2018
Q2
$5.62M Sell
101,611
-3,187
-3% -$172K 1.01% 30
2018
Q1
$6.63M Sell
104,798
-3,789
-3% -$244K 1.08% 28
2017
Q4
$6.65M Sell
108,587
-9,951
-8% -$622K 1.05% 30
2017
Q3
$7.56M Sell
118,538
-1,384
-1% -$80.8K 1.21% 25
2017
Q2
$6.68M Sell
119,922
-1,200
-1% -$65.3K 1.09% 25
2017
Q1
$6.59M Buy
121,122
+879
+0.7% +$48.2K 1.09% 25
2016
Q4
$7.03M Buy
120,243
+3,102
+3% +$170K 1.21% 25
2016
Q3
$6.32M Buy
117,141
+177
+0.2% +$11.4K 1.1% 25
2016
Q2
$8.6M Sell
116,964
-5,380
-4% -$380K 1.5% 17
2016
Q1
$7.82M Sell
122,344
-1,616
-1% -$102K 1.37% 19
2015
Q4
$8.53M Sell
123,960
-3,293
-3% -$218K 1.53% 18
2015
Q3
$7.53M Sell
127,253
-2,475
-2% -$157K 1.41% 22
2015
Q2
$8.63M Sell
129,728
-1,746
-1% -$115K 1.41% 21
2015
Q1
$8.48M Sell
131,474
-2,056
-2% -$129K 1.35% 21
2014
Q4
$7.88M Sell
133,530
-2,379
-2% -$134K 1.23% 23
2014
Q3
$6.96M Sell
135,909
-2,083
-2% -$104K 1.12% 26
2014
Q2
$6.69M Sell
137,992
-7,919
-5% -$390K 1.02% 30
2014
Q1
$7.58M Sell
145,911
-1,725
-1% -$91.8K 1.1% 29
2013
Q4
$7.85M Sell
147,636
-4,141
-3% -$211K 1.12% 28
2013
Q3
$7.02M Sell
151,777
-5,120
-3% -$225K 1.05% 31
2013
Q2
$7.01M Buy
+156,897
New +$6.81M 1.05% 28

Other funds holding BMY

NBT Bank's BMY Position: Q1 2026 in Review

NBT Bank reduced its Bristol-Myers Squibb (BMY) stake by 1.8% in Q1 2026, selling an estimated $61.5K and leaving 56,481 shares worth $3.43M. The position accounts for 0.22% of the portfolio, ranked #103.

NBT Bank first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.63M in Q2 2015. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • NBT Bank held 56,481 shares of Bristol-Myers Squibb worth $3.43M as of Q1 2026.
  • NBT Bank sold 1,055 Bristol-Myers Squibb shares in Q1 2026, an estimated $61.5K.
  • Bristol-Myers Squibb made up 0.22% of NBT Bank's portfolio in Q1 2026, its #103 holding.
  • NBT Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • NBT Bank's Bristol-Myers Squibb position peaked at $8.63M in Q2 2015.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on NBT Bank's 13F filing for Q1 2026, filed 28 Apr 2026.